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Objectives. The aim of this study was to determine the etiologic
factors in the formation of significant pericardial effusion after
oethalopte heart transplantation and to determine the association
of pericardial effusion with survival .
Background
.
The formation of pericardial effusions has been
well described after ortiatopie heart transplantation, but the risk
factors for development of effusions remain unclear . Rejection
and cyciesporiae have been cited as possible causes, but anatomic
factors have not been studied,
Me"
.
We conducted a retrospective review of medical
records and echocardiograms of 203 consecutive patients at one
center, facilitating ischendc time, incidence and severity of rejec-
tion, weight difference between donor and recipient and previous
cardiac surgical history . Multivariate analysis was performed,
and actuarial survival rate curves were calculated according to the
Kaplaa-Meler method .
The development of small to moderate pericardial effusions
after orthotopic heart transplantation has been well de-
scribed (1-4), and their incidence appears to be similar to
that after other types
of cardiac surgery (5,6)
. However, the
development of clinically significant pericardial effusions is
uncommon. The clinical characteristics and risk factors for
the development of these pericardial effusions after cardiac
transplantation remain unclear .
Valentine et al . (3) have described an association between
progressively enlarging pericardial effusions and the pres-
ence of myocyte rejection. The majority of these pericardial
effusions were diagnosed in the early postoperative period
.
No other significant clinical characteristics were associated
with the development of small to moderate pericardial effu-
sions in this particular series . Other smaller series have not
demonstrated a clear association between ongoing myocyte
rejection and the development of pericardial effusions (2,4) .
Some investigators (1,2) have suggested that the frequency
of significant posttransplant pericardial effusions in the cy-
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Results. Eighteen (8.9%) of 203 transplant recipients devet-
aped moderate to large pericardial effusions. Forty-four percent
of patients required perleardiocentesis, and 28% subsequently
required pericardleetamy for management of the efinsioas. Mul.
tivariate analysis identified the presence of a positive weight
difference between recipient and dew (recipcent weight > donor
weight) and the lack of previous median sMnotosgy as the most
powerful predictors of effusion formation . No significant associa-
tion was found with rejection, There was no difference In actuarial
survival rate between patients with and without effusleers .
Conclusions. A positive mismatch in weight between recipient
and donor and the absence of previous cardiac surgery are
associated with the formation of
significant
pericardial effusions .
Closer monitoring of these patients at risk may be warranted,
(J Am Coll Cordial 1994;23 :1625-9)
closporin A era of immunosuppression has increased com-
pared with the incidence seen before the use of cyclosporin
A . However, studies to date have not addressed the role of
anatomic factors, such as weight mismatch between recipi .
ent and donor, and have been limited by relatively small
sample sizes.
Thus, the primary objective of this study was to identify
the specific clinical characteristics of the donor and recipient
patients, which may predict the development of significant
pericardial effusions after orthotopic cardiac transplantation .
A secondary objective was to elucidate the natural history of
patients with these pericardial effusions after cardiac trans-
plantation.
Methods
Study patients. A retrospective analysis of 202 consecu-
live patients who underwent orthotopic heart transplantation
at the Brigham and Women's Hospital between 1984 and
1992 was performed. A single patient underwent retransplan.
ration for graft arteriosclerosis . Thus, a total of 203 trans-
plant recipients were included in the study. All patients
received immunosuppressive therapy with cyclosporin A
and prednisone
. After 1988, azathioprine was gradually
included as part of the standard immunosuppression regi-
men . Preservation solutions and surgical technique remained
essentially unchanged over the course of the study period.
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Therapeutic pericardiocentesis was performed only in the
event of clinical signs or symptoms of decreased cardiac
output or echocardiographic signs suggestive of pericardial
tamponade, or both. Only the characteristics of the initial
presentation of pericardial effusion were considered in the
multivariate analysis .
The donor and recipient characteristics analyzed were the
following : United Network for Organ Sharing (UNOS) sta-
tus at the time of transplantation ; etiology of cardiomyopa-
thy leading to transplantation ; total ischemic time ; the tim-
ing, frequency and severity of myocyte rejection episodes as
they related to the appearance of pericardial effusions ; donor
and recipient weight, age, gender and eytontegalovirus anti-
body
status; presence or absence of azathioprine therapy;
year of transplant ; recipient left ventricular end-systolic and
end-diastolic dimensions by M-mode echocardiography ; use
of anticoagulation in the early postoperative period ; and
previous cardiac surgical history of the recipient. "Weight
mismatch" was calculated as the recipient weight minus the
donor weight. Thus, a positive weight mismatch represents a
recipient weight greater than the donor weight . During the
initial transplant experience at our center (1984 to 1988), a
maximal weight mismatch of ±25% was considered . Subse-
quently, in an attempt to increase the donor pool for poten-
tial recipients, we accepted donors who were ±50% of ideal
body weight of the recipient in the absence of moderate to
severe pulmonary hypertension . Data on recipient and donor
weights were available in all patients with effusions and in
179 of 185 patients without effusions .
Eehocardlosraphk criteria . All patients had at least one
echocardiographic study before hospital discharge after
transplantation and at routine 3- to 6-month posttransplant
intervals according to standard protocol . Interval echocar-
diographic studies were obtained only at the discretion of the
transplant physicians. An independent observer, utilizing
standard conventions in our echocardiography laboratory,
defined effusions as small, moderate and large . Only moder-
ate and large pericardial effusions were considered in this
analysis
. Any diagnosis of pericardial effusion within the 1st
24 h after transplantation was not included, given the likeli-
hood of postoperative bleeding with or without hematoma
formation as the primary etiology .
Monitoring formyocyterejectlnn, Patients underwent en-
domyocardial biopsy according to a standard protocol at our
institution, Significant rejection was defined by the presence
of multiply foci of myocyte necrosis or diffuse myocyte
necrosis (International Society for Heart and Lung Trans-
plantation [ISHLT] grade a11tA) (7). For the purpose of
analyzing the potential relation between rejection and peri-
cardial effusion, any significant rejection observed within the
1st 60 days of transplantation or within ±30 days of the
diagnosis of the effusion was considered
.
Statist cal methods. All data are presented as mean val-
ues ± SEM unless otherwise indicated . Differences in char-
acteristics among patients with and without pericardial effu-
sions were compared by chi-square analysis or the Fisher
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exact test for discrete variables and the unpaired Student
I
test for continuous variables . Multivariate analysis was also
performed using a logistic stepwise regression model with
relation to the development of pericardial effusions . Actuar-
ial survival rate comes were calculated according to the
Kaplan-Meier method and were compared using the gener-
alized Wilcoxon test . A significant result was defined if the
null hypothesis could be rejected at the 0 .05 level.
Results
A total of 18 patients (14 men, 4 women) developed
pericardial effusions that were considered by echocardio-
graphic criteria to be moderate or large (Table 1). The
' verag time to detection of the pericardial effusion was 12 .6
days (range 4 to 28) after cardiac transplantation. Eight
patients required pericardiocentesis at a mean of 35 t 15
days (range 0 to 130) from the time of diagnosis of effusion.
In one patient, close surveillance was obtained over a period
of 130 days, when sudden hypotension developed with
echocardiogrophic signs suggestive of tamponade requiring
intervention . The laid from all of these patients was sero-
sanguinous and without evidence of active infection . Five
(27.9%) of 18 patients required surgical pericardiectomy for
recurrent large and symptomatic pericardial effusion after
repeated pericardiocemeses.
None of the 18 patients with pericardial effusions lad
cardiac surgery before transplantation compared with 67 of
the 185 patients without pericardial effusions who had pre-
vious cardiac surgery (p < 0.05) (fable 2). In addition,
patients with a positive weight mismatch were much more
likely to develop effissionns (Table 2) . The mean positive
difference between recipient and donor weights in the 18
patients with pericardial effusions was 11 .9 s 4.1 versus
2.2 t 1 .11* in the group of patients without significantly
large effusions (p = 0.01) . Using a logistic regression model,
the presence of a positive weight mismatch and the absence
of previous cardiac surgery would have correctly predicted
83% of the patients who developed moderate or large peri-
cardial effusions (sensitivity 83%, specificity 63%) (Table 3)
.
When the absolute magnitude of the weight mismatch was
analyzed, it did not improve sensitivity .
Myocyte rejection occurring within 30 days of the detec-
tion of these effusions was identified in 6 (33%) of 18
patients. To compare the incidence of rejection in patients
with and without significant effusions, the development of
rejection at any time within the Ist 60 days after transplant in
patients without significant effusions was calculated . There
was no difference in the incidence or frequency of rejection
between the two groups .
Total ischemic time, duration of cardiac bypass, recipient
or donor gender or age, cytomegalovirus status of the
recipient or donor, cause of cardiomyopathy, preoperative
recipient ventricular size by two-dimensional echocardiog-
raphy (left ventricular end-systolic and end-diastolic dimen-
sions), need for preoperative pressor or mechanical support,
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postoperative use of anticoagulant or antiplatelet agents.
azathioprine use or United Network for Organ Sharing
status at the time of transplantation were not independent
predictors for the development
or pericardial effusion .
Multivariate analysis also identified the year in which the
transplant was perforated as an independent predictor for
the development
of
moderate or large effusions . Since 1989,
our program has increased the limit of
weight acceptability
for potential donors from ±25% to ±50% in an attempt to
increase our potential donor pool . Accordingly, the inci-
dence of pericardial effusions has also increased over this
interval, with 15 of 18 of the effusions diagnosed between
1989 and 1992 (p = 0.06
by the Fisher exact test). Finally, by
Kaplan-Meter analysis (Fig. 1), although the sample size is
small, there was no clear decrease in actuarial survival in
patients with pericardial effusion (p = 0.23) .
Discussion
Pericardial effusions have been noted after all forms
of cardiac surgery (5,6), but controversy exists with regard
Teak 2. :2inieal Characteristics of Patients With and Without
Moderate or large Pericardial Effusions*
Ischemk Recipient
Donor
	
Weight
Time Age Age Previous Mismatch
(mint (yd (yet
Operation (kg)
Ps with 180±13 44 s3 27*-3
0%'
11.9x4.1'
efusiaas
Pis without 166 x 4
47 x 1 28 x 1 3670 21 ± 1 .1
'Fusion
'p < 0.05. Data Presented are mean values ± SEM
. Rs = patients.
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Table 1. Clinical Characteristics of Patients With Moderate or Large Pericardial Effusions
'Tine tram transplantation to diagnosis of pericardial effusion. (Grade AIIIA by International Society of Heart
end Lung Transplantation criteria 0000enrg within 30 days of dio.-otmsis of effusion. 3Recipient weight mines donor
weight
. ¢From any cause within 90 days of transplantation
. DCM
- idiopathic dilated cardiwgvopathy; Da =
diagnosis; ICM = ischemic cardiomyopathy ; Pt = patient,
to the significance of large pericardial effusions after
orthotopic heart transplantation. In this study, 18 (8 .9%) of
203 consecutive patients who underwent orthotopic heart
transplantation developed moderate or large pericardial ef-
fusions. The independent predictors for effusion formation
were lack of previous cardiac surgery, a positive recipient-
donor weight mismatch and the year the transplant was
performed . In addition, the presence of both the lack of
previous cardiac surgery and a positive weight mismatch
would have correctly predicted 83% of the patients who
developed these effusions
. The weight mismatch risk
factor is further supported by the fact that 15 of
18
of
the
pericardial effusions occurred during the time interval when
our program, in an attempt to broaden the donor pool (8),
broadened donor weight limits . Finally, Kaplan-Meier sur-
vival analysis did not demonstrate any difference in actuarial
survival rates in patients with moderate or large pericardial
effusions.
Risk factors for pericardia: effusion formation . The devel-
opment of pericardial effusion after orthotopic heart trans-
plantation was first described
by Barnard (9) after his first
two successful heart transplantations performed in South
Africa. However, no consensus with regard to specific risk
factors has been established
. Some investigators (1,2) have
suggested that the use of cyclosporin immunosuppression is
associated with an increased incidence of the development
of pericardial effusions . In our study, because all patients
were treated with cyclosporin, we cannot specifically ad-
dress the issue
of whether cyclosporin contributes to the
overall incidence of pericardial effusions . Further, the use of
azathioprine, which was gradually initiated in our program
Pt NoJGender Age (yr) Do
Time
Previous
(days) Rejectiont Cardiac Surgery
Weighty
(kg)
Death§
I/M 19 DCM 13 -22.6
2/M 49 ICM 28 +12.0
3IM 61 DCM 17 +4.0
4/M 25 DCM 13 -6 .0
5/F 48 DCM 6
+
+13 .9
6/M 33 DCM 4 -6.0
7/F 52 DCM 6 +3 .0
8/F 57 12CM 8 +7.0
91M 53 ICM 15 +2.0
I0/M 41 DCM 25 +4.0
11167 57 ]CM 7 +11 .0
121M 51 ICM 6
+34
.0
15/M
43
[CM
6 +41 .0
14/M
47 DCM 25 +27.0
151M 29 DCM 5 +34.2
INM 29 DCM 4 +41.0
17/M
59 DCM 15 +3.0
181E
32
ICM
14
+11 .0
IACC V.I. 23, No. 7
PERICARDIAL EFFUSION IN CARDIAC TRANSPLANT
	
Jot¢ 1994:16759
1628 HAUPTMAN ET AL .
Table 3. Relation Between History of Candia0 Surgery, Donor-Recipient Weight Mismatch and
Pericardial Effusion Formation
Pis with effusions
Pt, without effusions
PO = palitOts .
after 1988, was not an independent predictor of effusion
formation in the multivariate analysis .
In a comprehensive series describing effusion formation,
Valantine et al . (3)
diagnosed
new small, moderate and large
pericardial effusions in 12 of 189 patients who had undergone
orthotopic heart transplantation during a 1-year survey . All
but two of the pericardial effusions occurred within I month
of transplantation . Moderate
rejection was observed in en-
domyocardial biopsies performed at the time of the appear-
ance of these effusions in five patients. Subsequent biopsies
within I week of the diagnosis of pericardial effusion re-
vealed progression of myocyte rejection in all three patients
with mild degrees of rejection at the time of presentation and
in two of four patients initially free from rejection on
presentation
. A single patient developed a significant peri-
cardial effusion associated with myocyte rejection >4 years
after transplantation. The investigators
concluded
that the
development of pericardial effusion was significantly associ-
ated with myocyte rejection . In our analysis, because the
mean time to appearance of significant pericardial effusion
was 12.6 days, we compared the frequency of rejection in
this group to the incidence of significant rejection in all
patients during the 1st 60 days after transplantation . This
period encompasses multiple biopsies for each patient with
an effusion . There was no difference between the patients
with or without significant effusions
. Thus, in our series,
there does not appear to be a clear association between
Figure 1. Kaplan-Meier survival rate curve comparing patients with
and without pericardial effusions (perk . ef, PE) after cardiac
transplantation .
% Survival
too	
._.---
ao
9o
70
eo
so
40
30
20
0 0
0
a 12
Interval From Transplant (Months)
No Pmsioos Operadon No Previous OPemdon Previous Operation Previous Operation
cad Positive and Negative and Positive am Negative
Weight Mismatch Weight Mismatch
Weight
Mismatch Weight Mismatch
15 3 0 0
61 52 44 22
+'qra. all, -
0
- no Pu
effusion formation and myocyte rejection in the early post-
operative setting. This conclusion, however, may be limited
by the absence of simultaneous biopsy and echocardio-
graphic evaluations and by consideration of moderate and
large effusions only.
Abeeme of previous cardiac surgery as a risk factor far
perkardld eIudon fermu te.
. No study to date has directly
considered anatomic factors in effusion formation, including
the effect of previous thoracic surgery and the role of
recipient heart size
. In our study, none of the patients with
moderate or large effusions had previous cardiac surgery
compared with 36% of patients without these effusions
.
Precedence for this finding may be found in another study of
postoperative transplant recipients (4),
in which effusions
were more common in patients with a preoperative diagnosis
of idiopathic dilated cardiomyopethy . In this study, neither
the diagnosis of idiopathic dilated cardiomyopatlty nor pre-
operative recipient ventricular size appear, by multivariable
analysis, to be predictors of effusion formation . Rather,
idiopathic dilated cardromyopatby may be a surrogate
marker for the absence of previous cardiac surgery .
Daaot+redpkat weight whookk as a rhk factor for
per'
eardiaf dlhswt farlaadoa . A positive donor-recipient weight
mismatch was more common in patients with significant
pericardial effusions . In our series, the use of donors with
greater weight discrepancy has paralleled the increased
incidence of significant effusions over the period studied . It
is possible that a relatively well preserved pericardium in
patients without previous cardiac surgery and a large
recipient-donor weight mismatch would provide anatomy
that may favor the exudation of fluid into the pericardial
space. This analysis is limited by the use of donor and
recipient weight as a surrogate for ventricular volumes .
Because heart size may not be proportional to loan body
mass, donor and recipient weights may be only a crude
measurement of ventricular volumes . Direct comparison of
ventricular volumes of the donor and recipient may serve as
a better index for establishing the role of size mismatch .
Conclusions. Significant pericardial effusions occur coin-
monly in patients with a positive weight mismatch and no
previous cardiac surgery. Closer noninvasive follow-up in
the early postoperative period may be indicated
. Further,
increasing the time of mediastinal drainage and other pro-
phylactic measures may be considered . We are currently
examining the role of pericardial window and partial pericar-
JACC Val
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dial
. resection in patients at risk . Prevention of significant
pericardial effusion formation after orthotopic heart trans-
plantation will reduce postoperative morbidity
.
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